Crinetics Pharma (CRNX)
NASDAQ:CRNX
Want to see CRNX full AI Analyst Report?
Crinetics Pharmaceuticals (CRNX) Ownership Overview
1.92% Insiders
38.41% Mutual Funds
42.87% Other Institutional Investors
15.27% ETFs
1.54% Public Companies and
Individual Investors
The ownership structure of Crinetics Pharmaceuticals (CRNX) stock is a mix of institutional, retail, and individual investors. Approximately 96.54% of the company’s stock is owned by Institutional Investors, 1.92% is owned by Insiders, and 1.54% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $302839719 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $27701337 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $232299887 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $1191913 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,134,796 | Institution | 8.66% | 328,944,004 | |
| 8,338,098 | Institution | 7.91% | 300,254,909 | |
| 8,257,421 | Institution | 7.83% | 297,349,730 | |
| 6,395,922 | Institution | 6.07% | 230,317,151 | |
| 5,249,198 | Institution | 4.98% | 189,023,620 | |
| 4,612,932 | Institution | 4.37% | 166,111,681 | |
| 3,494,255 | Institution | 3.31% | 125,828,123 | |
| 2,351,465 | Institution | 2.23% | 84,676,255 | |
| 2,329,471 | Institution | 2.21% | 83,884,251 | |
| 1,581,817 | Institution | 1.50% | 56,961,230 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,257,421 | Institution | 7.83% | 297,349,730 | |
| 5,249,198 | Institution | 4.98% | 189,023,620 | |
| 3,494,255 | Institution | 3.31% | 125,828,123 | |
| 2,329,471 | Institution | 2.21% | 83,884,251 | |
| 1,581,817 | Institution | 1.50% | 56,961,230 | |
| 1,571,543 | Institution | 1.49% | 56,591,263 | |
| 1,234,470 | Institution | 1.17% | 44,453,265 | |
| 1,119,672 | Institution | 1.06% | 40,319,389 | |
| 1,097,907 | Institution | 1.04% | 39,535,631 | |
| 1,094,456 | Institution | 1.04% | 39,411,361 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,351,384 | Institution | 3.18% | 121,722,267 | |
| 2,418,842 | Institution | 2.29% | 87,852,341 | |
| 2,282,006 | Institution | 2.16% | 84,228,841 | |
| 1,351,035 | Institution | 1.28% | 49,069,591 | |
| 1,143,673 | Institution | 1.08% | 41,538,203 | |
| 805,844 | Institution | 0.76% | 29,743,702 | |
| 717,419 | Institution | 0.68% | 26,479,935 | |
| 500,135 | Institution | 0.47% | 18,279,934 | |
| 481,354 | Institution | 0.46% | 17,482,777 | |
| 268,469 | Institution | 0.25% | 9,750,794 |
FAQ
Who Owns Crinetics Pharma (CRNX)?
According to the latest TipRanks data, approximately 42.87% of the company's stock is held by institutional investors, 1.92% is held by insiders, and 1.54% is held by retail investors.
What percentage of Crinetics Pharma (CRNX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 42.87% of Crinetics Pharma (CRNX) stock is held by institutional investors.
What percentage of Crinetics Pharma (CRNX) stock is held by retail investors?
According to the latest TipRanks data, approximately 1.54% of Crinetics Pharma (CRNX) stock is held by retail investors.
Who owns the most shares of Crinetics Pharma (CRNX)?
Vanguard owns the most shares of Crinetics Pharma (CRNX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.